Brevan Howard Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41K Sell
19,806
-57,735
-74% -$120K ﹤0.01% 1722
2025
Q1
$171K Buy
+77,541
New +$171K ﹤0.01% 963